KMS, By choosing RETTS AND FRAGX, NEU can get Orphan Staus and Fast Track Designation....really quick to market, then Doctors will quickly go OFF LABEL for ASD's and TBI's and any Neuropathy conditions...
Otherwise sufferers would be waiting forever for treatments which could easily be available..
So its a really compelling investment opportunity.. BTW. NEU have beem visiting Brokers in the last few weeks explaining the NEO Story..
The brokers are very impressed. With the presentation..
PBT has adopted the same strategy by prioritising Huntingtons Disease which will fly off label to Alzheimers Disease and Parkinsons Xisease.
See my post on the BIOTECH thread.
undervalued?, page-65
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
-0.540(2.81%) |
Mkt cap ! $2.383B | |||
| Open | High | Low | Value | Volume |
| $18.98 | $19.15 | $18.50 | $10.51M | 560.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $18.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.65 | 1127 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |